Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2012 | Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions | Lin Y.-Y.; Hsu Y.-H.; Huang H.-Y.; Shann Y.-J.; Huang C.-Y.F.; SHU-CHEN WEI ; Chen C.-L.; Jou T.-S. | Journal of Clinical Investigation | 21 | ||
1997 | Acute pancreatitis complicated by infarction of the spleen and spinal cord | SHU-CHEN WEI ; Kao J.-H.; Lee W.-Y.; Lin J.-T.; Wang T.-H. | Journal of the Formosan Medical Association | 2 | ||
2007 | Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis | Chang M.-C.; Chang Y.-T.; Su T.-C.; Yang W.-S.; Chen C.-L.; Tien Y.-W.; Liang P.-C.; SHU-CHEN WEI ; Wong J.-M. | Pancreas | 50 | ||
2011 | Alcoholic pancreatitis complicated by an intra-abdominal abscess | Weng M.-T.; Tsang Y.-M.; SHU-CHEN WEI | Gastroenterology | 0 | ||
2016 | Aptamer-based colorimetric detection of proteins using a branched DNA cascade amplification strategy and unmodified gold nanoparticles | Chang C.-C.; Chen C.-Y.; Chuang T.-L.; Wu T.-H.; SHU-CHEN WEI ; Liao H.; Lin C.-W. | Biosensors and Bioelectronics | 59 | ||
2016 | Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus-Part 1) | Ooi C.J.; Makharia G.K.; Hilmi I.; Gibson P.R.; Fock K.M.; Ahuja V.; Ling K.L.; Lim W.C.; Thia K.T.; SHU-CHEN WEI ; Leung W.K.; Koh P.K.; Gearry R.B.; Goh K.L.; Ouyang Q.; Sollano J.; Manatsathit S.; de Silva H.J.; Rerknimitr R.; Pisespongsa P.; Abu Hassan M.R.; Sung J.; Hibi T.; Boey C.C.M.; Moran N.; Leong R.W.L.; on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease | Journal of Gastroenterology and Hepatology (Australia) | 41 | ||
2010 | The Asia-Pacific consensus on ulcerative colitis | Ooi C.J.; Fock K.M.; Makharia G.K.; Goh K.L.; Ling K.L.; Hilmi I.; Lim W.C.; Kelvin T.; Gibson P.R.; Gearry R.B.; Ouyang Q.; Sollano J.; Manatsathit S.; Rerknimitr R.; SHU-CHEN WEI ; Leung W.K.; De Silva H.J.; Leong R.W. | Journal of Gastroenterology and Hepatology (Australia) | 95 | ||
2016 | Asia-Pacific consensus statements on Crohn's disease. Part 2: Management | Ooi C.J.; Makharia G.K.; Hilmi I.; Gibson P.R.; Fock K.M.; Ahuja V.; Ling K.L.; Lim W.C.; Thia K.T.; SHU-CHEN WEI ; Leung W.K.; Koh P.K.; Gearry R.B.; Goh K.L.; Ouyang Q.; Sollano J.; Manatsathit S.; de Silva H.J.; Rerknimitr R.; Pisespongsa P.; Abu Hassan M.R.; Sung J.; Hibi T.; Boey C.C.M.; Moran N.; Leong R.W.L.; on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease | Journal of Gastroenterology and Hepatology (Australia) | 24 | ||
2018 | Asian organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Intestinal Research | 11 | ||
2018 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Journal of Gastroenterology and Hepatology (Australia) | 9 | ||
2018 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management | Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Intestinal Research | 7 | ||
2020 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia | Ran Z.; Wu K.; Matsuoka K.; Jeen Y.T.; SHU-CHEN WEI ; Ahuja V.; Chen M.; Hu P.-J.; Andoh A.; Kim H.J.; Yang S.-K.; Watanabe M.; Ng S.C.; Hibi T.; Hilmi I.N.; Suzuki Y.; Han D.S.; Leung W.K.; Sollano J.; Ooi C.J.; Qian J. | Journal of Gastroenterology and Hepatology (Australia) | 0 | ||
2018 | Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment | Park D.I.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI ; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. | Journal of Gastroenterology and Hepatology (Australia) | 3 | ||
2020 | Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic | Ling K.L.; Hilmi I.; Raja Ali R.A.; Leong R.W.L.; Leung W.K.; Ng S.C.; Wu K.C.; Chen M.H.; Ran Z.H.; Hisamatsu T.; Ahuja V.; Makharia G.K.; Banerjee R.; SHU-CHEN WEI ; Wu D.C.; Pisespongsa P.; Ye B.D.; Sollano J.; Simadibrata M.; Chuah S.W.; Ooi C.J. | JGH Open | 3 | ||
2009 | Association and differential role of PRSS1 and SPINK1 mutation in early-onset and late-onset idiopathic chronic pancreatitis in Chinese subjects | Chang Y.-T.; SHU-CHEN WEI ; L P.-C.; Tien Y.-W.; Jan I.-S.; Su Y.-N.; Wong J.-M.; Chang M.-C. | Gut | 23 | ||
2008 | Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation/variant/haplotype and Tumor Necrosis Factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis | Chang Y.-T.; Chang M.-C.; Su T.-C.; Liang P.-C.; Su Y.-N.; Kuo C.-H.; SHU-CHEN WEI ; Wong J.-M. | Clinical Chemistry | 44 | ||
2009 | Association of novel chymotrypsin C gene variations and haplotypes in patients with chronic pancreatitis in Chinese in Taiwan | Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI ; Liang P.-C.; Jan I.-S.; Su Y.-N.; Kuo C.-H.; Wong J.-M. | Pancreatology | 18 | ||
2006 | Association of tumour necrosis factor α promoter haplotype with chronic pancreatitis [20] | Chang M.-C.; Chang Y.-T.; Tien Y.-W.; Liang P.-C.; SHU-CHEN WEI ; Wong J.-M. | Gut | 11 | ||
2009 | Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status | Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI ; Kuo C.-H.; Liang P.-C.; Wong J.-M. | Pancreas | 21 | ||
2017 | Balloon-assisted enteroscopy and capsule endoscopy in suspected small bowel Crohn’s disease | Yen H.-H.; Chang C.-W.; Chou J.-W.; SHU-CHEN WEI | Clinical Endoscopy | 7 |